Available from: www.nature.com/nrendo Muscogiuri G, DeFronzo RA, Gastaldelli A, et al
Combination with metformin and/or thiazolidinediones In a 56-week, double-blind trial (NCT01930188), 1231 patients with type 2 diabetes mellitus were randomized to OZEMPIC0.5 mg once weekly, OZEMPIC1 mg once weekly, or sitagliptin 100 mg once daily, all in combination with metformin (94%) and/or thiazolidinediones (6%)
Thanks for clearing that up
Semaglutide's Efficacy, Safety, and Limitations Clinical trials like STEP 1 and SURMOUNT-1 (for a related medication, tirzepatide) have demonstrated significant weight loss using GLP-1 receptor agonists
The aim of this narrative review was to summarise the available evidence on the usefulness of acetyl-l-carnitine in the treatment of peripheral neuropathies
Foundayo is a notable addition